SEC Contract Filing

Filing Date: 2016-11-22

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>fate-ex102_69.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
fate-ex102_69.htm
</title>
</head>
<!-- NG Converter v4.0.5.11 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.2</p>
<p style="margin-bottom:12pt;text-align:center;margin-top:0pt;text-indent:0%;font-size:11pt;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-style:normal;font-variant: normal;">REGISTRATION RIGHTS AGREEMENT</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Registration Rights Agreement (this &#8220;<font style="font-weight:bold;text-decoration:underline;">Agreement</font>&#8221;) is made and entered into as of November 21, 2016, by and among Fate Therapeutics, Inc., a Delaware corporation (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Company</font>&#8221;), and the several purchasers signatory hereto (each a &#8220;<font style="font-weight:bold;text-decoration:underline;">Purchaser</font>&#8221; and collectively, the &#8220;<font style="font-weight:bold;text-decoration:underline;">Purchasers</font>&#8221;).</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof between the Company, each Purchaser and certain other purchasers (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Purchase Agreement</font>&#8221;).</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each of the Purchasers agree as follows: </p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:0pt;"></font><font style="text-decoration:underline;">Definitions</font>.&nbsp;&nbsp;Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.&nbsp;&nbsp;As used in this Agreement, the following terms shall have the following meanings:</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;text-decoration:underline;">Affiliate</font>&#8221; means, with respect to any person, any other person which directly or indirectly controls, is controlled by, or is under common control with, such person.</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;text-decoration:underline;">Business Day</font>&#8221; means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction of business.</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="text-decoration:underline;">Commission</font>&#8221;<font style="font-weight:normal;"> means the Securities and Exchange Commission.</font></p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;text-decoration:underline;">Common Stock</font>&#8221; means the common stock of the Company, par value $0.001 per share, and any securities into which such common stock may hereinafter be reclassified. </p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;text-decoration:underline;">Cut-Back Shares</font>&#8221; shall mean any Registrable Securities that, by virtue of the Commission informing the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement as provided in <font style="text-decoration:underline;">Section 2(a)</font> below, cannot be registered on the Registration Statement or the New Registration Statement. </p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;text-decoration:underline;">Effective Date</font>&#8221; means the date that the Registration Statement filed pursuant to <font style="text-decoration:underline;">Section 2(a)</font> is first declared effective by the Commission.</p>
<p style="text-align:left;margin-bottom:12pt;margin